Offer Cologuard to every eligible patient aged 45 and older at average risk for colorectal cancer (CRC)1

female patient with cologuard kit
See major guidelines that include Cologuard

FAP=familial adenomatous polyposis; IBD=Inflammatory bowel disease; UC=ulcerative colitis.

*
Such as hereditary nonpolyposis CRC syndrome (or Lynch syndrome), Peutz-Jeghers syndrome, MYH-associated polyposis, Gardner's syndrome, Turcot's (or Crail's) syndrome, Cowden's syndrome, juvenile polyposis, Cronkhite-Canada syndrome, neurofibromatosis, or familiaI hyperplastic polyposis.1

 

References: 1. Cologuard® Clinician Brochure. Madison, WI: Exact Sciences Corporation. 2. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281.